Prestige Institute For Plastic Surgery, PC v. Aetna, Inc.

CourtDistrict Court, D. Connecticut
DecidedJune 20, 2025
Docket3:23-cv-00940
StatusUnknown

This text of Prestige Institute For Plastic Surgery, PC v. Aetna, Inc. (Prestige Institute For Plastic Surgery, PC v. Aetna, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Prestige Institute For Plastic Surgery, PC v. Aetna, Inc., (D. Conn. 2025).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT

PRESTIGE INSTITUTE FOR PLASTIC SURGERY, JENNIFER REESE, Plaintiffs, No. 3:23-cv-0940 (VAB) v.

AETNA LIFE INSURANCE COMPANY, GEORGE ALLEN WASTEWATER MANAGEMENT, Defendants.

RULING AND ORDER ON MOTION TO AMEND Jennifer Reese (“Plaintiff”) has filed a motion for leave to amend, with a proposed Amended Complaint alleging in Count One, failure to make payments according to member’s plan under Section 502(a)(1) of the Employee Retirement Income Security Act (“ERISA”); in Count Two, breach of fiduciary duty under ERISA; and in Count Three, failure to establish a summary plan description that complies with ERSIA, against Aetna Life Insurance Company (“Aetna”) and George Allen Wastewater Management (collectively, “Defendants”). Defendants oppose the motion for leave to amend. For the following reasons, the motion for leave to amend is GRANTED. The parties are instructed to engage in discovery, only as specifically provided for in this Ruling and Order until September 5, 2025, and to file any dispositive motions, again only as specifically provided for in this Ruling and Order, by October 3, 2025. I. FACTUAL AND PROCEDURAL BACKGROUND A. Factual Allegations Ms. Reese has a history of breast cancer. Proposed Am. Compl. ¶ 14, ECF No. 36 (Oct. 24, 2024) (“Am. Compl.”).

On July 16, 2019, Dr. Joseph Tamburrino, a plastic surgeon associated with Prestige Institute for Plastic Surgery (“Prestige”), completed breast reconstruction surgery on Mr. Reese. Id. ¶ 15-17. Before the surgery, Prestige allegedly sought and received written approval from Aetna pre-authorizing insurance coverage of the surgery, based on the specific billing codes for the surgery. Id. ¶¶ 17–20. After the surgery, Prestige submitted a claim of $100,000 to Aetna for the pre-authorized surgery. Id. ¶¶ 21–22. The cost was allegedly a “usual and customary charge[]” for the complex procedure performed by Dr. Tamburrino. Id. Aetna allegedly paid $1,071.27 on the claim, leaving a balance of $98,928.73 to be paid

by Ms. Reese. Id. ¶ 23. Under the insurance plan, benefits for out-of-network providers are allegedly paid at “105% of Medicare allowable rate.” Id. ¶ 24. The procedure completed by Dr. Tamburrino— billing code S2068—allegedly does not have a Medicare allowable rate, and therefore Plaintiff alleges it “must be paid at its billed charge of $100,000.” Id. ¶ 26. Ms. Reese’s reconstruction additionally required a second-stage surgery. Id. ¶ 27. For the second stage of the reconstruction, Prestige allegedly again sought pre- authorization of coverage from Aetna. Id. ¶ 28. On January 15, 2020, Prestige allegedly received specific pre-authorization based on the billing codes for the second-stage surgery. Id. ¶ 29. On January 29, 2020, the surgery for the second stage of reconstruction was completed on Ms. Reese. Id. ¶ 30.

On the same day, the claim was submitted to Aetna for the second-stage surgery, totaling $22,179.82. Id. ¶ 31. Aetna allegedly denied payment of this bill. Id. ¶ 32. The total billed charges for the allegedly pre-authorized surgeries was $122,179.82. Id. ¶ 34. Of these charges, Aetna allegedly paid $1,071.27, leaving a balance of $121,108.55. Id. ¶ 35. Aetna allegedly knew that Prestige was an out-of-network provider, but “never disclosed that it did not intend to pay the usual and customary value” for the surgeries completed. Id. ¶ 36. B. Procedural History On July 15, 2023, Prestige filed a Complaint against Aetna and George Allen Wastewater Management. Compl., ECF No. 1 (July 15, 2023) (“Compl.”). On October 23, 2023, Defendants filed a motion to dismiss Prestige’s Complaint. Mot. to

Dismiss, ECF No. 27 (Oct. 23, 2023). On December 12, 2023, Prestige filed a response to the motion to dismiss. Response, ECF No. 30 (Dec. 12, 2023). On January 19, 2024, Defendants filed a reply to the response to the motion to dismiss. Reply to Response, ECF No. 33 (Jan. 19, 2024). On September 30, 2024, the Court granted the motion to dismiss and dismissed all claims filed by Prestige with prejudice. Order on Mot. to Dismiss, ECF No. 34 (Sept. 30, 2024) (“Order on Mot. to Dismiss”). The Court allowed the patient—now identified as Ms. Reese—to move for leave to amend to the extent she could “bring her ERISA claims directly” in substitution for Prestige. Id. On October 24, 2024, Ms. Reese filed a motion for leave to amend. Mot. to Amend/Correct, ECF No. 36 (Oct. 24, 2024).

On December 6, 2024, Defendants filed a memorandum in opposition to the motion for leave to amend. Memo. in Opp., ECF No. 41 (Dec. 6, 2024). On January 3, 2025, Ms. Reese filed a reply to the memorandum in opposition. Reply, ECF No. 44 (Jan. 3, 2025) (“Reply”). On January 9, 2025, Defendants moved to file a sur-reply. Mot. for Leave to File Sur- Reply, ECF No. 45 (Jan. 9, 2025). On January 10, 2025, Ms. Reese objected to Defendants’ motion to file a sur-reply. Memo. in Opp., ECF No. 46 (Jan. 10, 2025). On the same day, the Court granted Defendants’ motion to file a sur-reply. Order, ECF No. 47 (Jan. 10, 2025). On January 17, 2025, Defendants filed a sur-reply. Reply to Response, ECF No. 48 (Jan.

17, 2025) (“Sur-Reply”). II. STANDARD OF REVIEW Under Federal Rule of Civil Procedure 15(a), “[a] party may amend its pleading once as a matter of course within: (A) 21 days after serving it, or (B) if the pleading is one to which a responsive pleading is required, 21 days after service of a responsive pleading or 21 days after service of a motion under Rule 12(b), (e), or (f), whichever is earlier.” Fed. R. Civ. P. 15(a)(1). “In all other cases, a party may amend its pleading only with the opposing party’s written consent or the court’s leave. The court should freely give leave when justice so requires.” Fed. R. Civ. P. 15(a)(2). The district court has broad discretion to decide a motion to amend. See Local 802, Assoc. Musicians of Greater N.Y. v. Parker Meridien Hotel, 145 F.3d 85, 89 (2d Cir. 1998). If a court chooses to deny leave to amend, however, it must give some “justifying reason” for doing so. Foman v. Davis, 371 U.S. 178, 182 (1962). Reasons for denying leave to amend include

“undue delay, bad faith or dilatory motive on the part of the movant, repeated failure to cure deficiencies by amendments previously allowed, undue prejudice to the opposing party by virtue of allowance of the amendment, [or] futility of amendment[.]” Id.; see also Lucente v. Int’l Bus. Machines Corp., 310 F.3d 243, 258 (2d Cir. 2002) (noting leave to amend may be denied when amendment is “unlikely to be productive,” such as when an amendment is “futile” and “could not withstand a motion to dismiss [under] Fed. R. Civ. P. 12(b)(6)”); Park B. Smith, Inc. v. CHF Indus. Inc., 811 F. Supp. 2d 766, 779 (S.D.N.Y. 2011) (“While mere delay, absent a showing of bad faith or undue prejudice, is not enough for a district court to deny leave to amend, the longer the period of an unexplained delay, the less will be required of the nonmoving party in terms of a showing of prejudice.” (internal quotation marks omitted)).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
KRUPSKI v. COSTA CROCIERE S. P. A
560 U.S. 538 (Supreme Court, 2010)
Staehr v. Hartford Financial Services Group, Inc.
547 F.3d 406 (Second Circuit, 2008)
Park B. Smith, Inc. v. Chf Industries Inc.
811 F. Supp. 2d 766 (S.D. New York, 2011)
Yuhas v. Provident Life & Casualty Insurance
162 F. Supp. 2d 227 (S.D. New York, 2001)
Del Greco v. CVS Corp.
337 F. Supp. 2d 475 (S.D. New York, 2004)
Cole v. Travelers Insurance
208 F. Supp. 2d 248 (D. Connecticut, 2002)
Manginaro v. Welfare Fund of Local 771, IATSE
21 F. Supp. 2d 284 (S.D. New York, 1998)
Heimeshoff v. Hartford Life & Accident Ins. Co.
134 S. Ct. 604 (Supreme Court, 2013)
Brown v. Rawlings Financial Services, LLC
868 F.3d 126 (Second Circuit, 2017)
Faryniarz v. Ramirez
62 F. Supp. 3d 240 (D. Connecticut, 2014)
Corpes v. Walsh Construction Co.
130 F. Supp. 3d 638 (D. Connecticut, 2015)
Korman v. Consolidated Edison Co. of New York, Inc.
915 F. Supp. 2d 359 (E.D. New York, 2013)
Fargas v. Cincinnati Machine, LLC
986 F. Supp. 2d 420 (S.D. New York, 2013)
Lorentangeli v. Critelli
692 F. Supp. 380 (D. New Jersey, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
Prestige Institute For Plastic Surgery, PC v. Aetna, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/prestige-institute-for-plastic-surgery-pc-v-aetna-inc-ctd-2025.